A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors

Recruiting

Phase 1

ASP4396A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors

Sponsor:

Astellas Pharma Inc

Code:

NCT06364696

Conditions

Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ASP4396

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-30. This information was provided to ClinicalTrials.gov by Astellas Pharma Inc on 2025-10-27.